Form 4: Edgewell Personal Care Executive Reports Stock Transactions Following Vesting of Equity Awards

Sentiment:

SEC Form 4 Filing


Edgewell Personal Care's President of North America, Eric F. O'Toole, reported multiple transactions involving the vesting and subsequent sale of company stock to cover tax liabilities.

Summary

  • Eric F. O'Toole, President of North America at Edgewell Personal Care, filed a Form 4 detailing changes in his beneficial ownership of company stock.
  • The transactions primarily involve the vesting of restricted stock equivalents and performance stock equivalents, which converted into common stock.
  • A portion of the newly vested shares were then sold to cover tax liabilities associated with the vesting.
  • On November 10, 2024, 3,215 restricted stock equivalents and 8,646 performance stock equivalents vested and converted to common stock.
  • On November 11, 2024, 2,516 restricted stock equivalents vested and converted to common stock.
  • A total of 1,491 shares were sold on November 10, 2024, at $36.13 per share to cover taxes related to the vesting of restricted stock equivalents.
  • An additional 4,008 shares were sold on November 10, 2024, at $36.13 per share to cover taxes related to the vesting of performance stock equivalents.
  • Finally, 1,167 shares were sold on November 11, 2024, at $36.13 per share to cover taxes related to the vesting of restricted stock equivalents.
  • Following these transactions, Mr. O'Toole's direct holdings of Edgewell common stock is 31,462 shares.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock transactions, which is neither positive nor negative for the company's performance.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, which is common practice and required by the SEC. It does not indicate any specific trend in the personal care industry.

Comparison to Industry Standards

  • Form 4 filings are standard practice for publicly traded companies in the US, and this filing is consistent with those requirements.
  • The vesting of stock awards and subsequent sale to cover taxes is a common practice for executives in many industries, including the personal care sector.
  • There are no specific comparible companies or projects mentioned in the document.

Stakeholder Impact

  • The transactions have a minor impact on shareholders as they involve the sale of shares by an executive, which could slightly increase the supply of shares in the market.

Key Dates

DateDescription
11/12/2021Date of original award of performance stock equivalents.
11/10/2023Date of original award of restricted stock equivalents.
11/11/2022Date of original award of restricted stock equivalents.
11/10/2024Vesting date of restricted and performance stock equivalents and sale of shares for tax liabilities.
11/11/2024Vesting date of restricted stock equivalents and sale of shares for tax liabilities.
11/13/2024Date of filing of the Form 4.

Keywords

Form 4, insider trading, stock transaction, equity compensation, restricted stock, performance stock, Edgewell Personal Care, EPC, Eric F. O'Toole

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.